NEWARK, Del, July 13, 2023 (GLOBE NEWSWIRE) -- The Global Single Cell Analysis System Market is poised to witness remarkable growth in the coming years, fueled by groundbreaking advancements in biomedical research. Single-cell analysis, a cutting-edge technology that enables the study of individual cells at the molecular level, has opened new frontiers in understanding complex biological processes and diseases.
The global Single Cell Analysis System Market is expected to grow substantially in the forthcoming years; market value was US$ 3.2 Billion in 2022 and is expected to reach US$ 7.2 Billion by 2033 at a CAGR of 7.8%. The market is primarily fueled by increasing demand for predictive testing, cancer diagnostics, stem cell research, and single-cell genomics.
One of the key drivers behind this surge is the growing emphasis on drug discovery and development. The pharmaceutical and biotechnology industries are experiencing a critical need for efficient tools and technologies that can provide comprehensive insights into cellular behavior, functions, and interactions. Single-cell analysis systems address this need by empowering researchers to study individual cells and unravel the complexities of cellular heterogeneity. Understanding cellular heterogeneity is paramount in deciphering disease mechanisms and determining drug responses.
Don't miss out on the opportunity to revolutionize drug discovery and development. Download Sample Report on the Single-Cell Analysis System Market today! https://www.futuremarketinsights.com/reports/sample/rep-gb-10237
As drug discovery and development continue to be a priority for the pharmaceutical industry, the demand for single-cell analysis systems is expected to grow. These systems provide a powerful toolset for researchers to explore the intricacies of cellular biology, enabling them to make breakthroughs in understanding diseases and developing innovative treatments.
Utilizing various technologies, such as manual, semi-automated, and automated systems, for single-cell analysis is a significant driver in the market. These diverse technological approaches cater to researchers' and scientists' different needs and preferences in conducting their studies. The availability of multiple options allows for flexibility and customization in single-cell analysis, enabling researchers to choose the most suitable system for their specific experimental requirements. This market driver reflects the importance of offering a range of technologies to accommodate the diverse needs of researchers and enhance the efficiency and accuracy of single-cell analysis.
Key Takeaways from the Single Cell Analysis System Market:
In the single-cell analysis market, consumables are the top product category, accounting for a 49.3% market value share in 2022. This segment drives market growth due to its widespread utilization in diagnostic testing applications.
- By system type, the automated cell analysis system holds the leading position with a market share of 42.0% in the single-cell analysis market in 2022, providing advanced and efficient solutions for studying individual cells.
- By application, receptor functional analysis accounted for 14.3% of the total market share in 2022.
- North America is the leading market by 36.9% market value share in 2022 in the single-cell analysis market, characterized by its strong presence of key market players, well-established healthcare infrastructure, and significant investments in research and development.
"The market's rapid growth is driven by the increasing demand for enhanced diagnostics and research in fields like cancer and stem cell studies. This demand creates significant opportunities for innovation and global expansion in the market." says an analyst of Future Market Insights.
Unleash Your Potential: Customize Your Report to Master the Single Cell Analysis System Market Landscape! https://www.futuremarketinsights.com/customization-available/rep-gb-10237
Recent Developments in Single Cell Analysis System Market and Branding and Promotional Strategies, By Key Players:
The omics field has started to evolve rapidly due to the advancement of technology and artificial intelligence intervention.
- In May 2023, Deepcell introduced REM-I, an AI-powered single-cell analysis platform that enables scalable imaging, high-dimensional analysis, and cell sorting for unprecedented insights into cell biology and morpholomics.
- In February 2023, Max Read Kits for single-cell applications are now available from Singular Genomics. The Max Read Kits are intended for use with the company's G4 Sequencing Platform for single-cell applications.
Major Key Players:
- 10x Genomics
- Fluidigm Corporation
- Bio-Rad Laboratories
- Illumina
- Takara Bio
- Agilent Technologies
- Mission Bio
- NanoString Technologies
- Thermo Fisher Scientific
- Miltenyi Biotec GmbH
- BGI Group
- Genotypic Technology Pvt. Ltd.
- SciGenom Labs Pvt. Ltd.
What Does the Report Cover?
In its newest analysis, Future Market Insights provides a unique viewpoint and actionable insights into the single-cell analysis system market. It gives a historical demand assessment from 2107 to 2022 and estimates from 2023 to 2033. The global single-cell analysis system market is divided in depth to cover every industry area and provide the reader with a comprehensive market intelligence approach.
The analysis is based on by system type (manual single cell analysis system, semi-automated cell analysis system, & automated cell analysis system), by product (instruments { flow cytometers, polymerase chain reaction, mass spectroscopy, next generation sequencing systems, high content screening systems, automated cell counters, microscopes, cell microarrays, hemocytometers, and, others}, consumables and software), by technology (time-lapse microscopy, fluorescence microscopy, confocal microscopy, total internal reflection fluorescence (TIRF), microscopy microfluidics-based systems, impedance-based analysis biosensors and fluorescent probes & others), by application (cell viability and proliferation, apoptosis, compound mediated cytotoxicity, receptor functional analysis, pathogen detection, viral studies, gene expression, stem cell monitoring, angiogenesis, immunocytochemistry, cell cycle analysis, drug screening cell, culture monitoring, & other application), by end user (hospitals and diagnostic laboratories, pharma & biopharmaceutical companies, academic and research organization, & contact research organization), and across 7 regions of world.
Gain Immediate Access to Detailed Market Insights: Purchase Now to Uncover Segment-specific Information, Identify Key Trends, Drivers, and Challenges! https://www.futuremarketinsights.com/checkout/10237
Key Market Segments Covered in the Single Cell Analysis System Industry Research
By Product:
- Instruments
- Flow Cytometers
- Polymerase Chain Reaction
- Mass Spectroscopy
- Next Generation Sequencing Systems
- High Content Screening Systems
- Automated Cell Counters
- Microscopes
- Cell Microarrays
- Hemocytometers
- Others
- Consumables
- Softwares
By System Type:
- Manual Single Cell Analysis System
- Semi-Automated Cell Analysis System
- Automated Cell Analysis System
By Application:
- Viral studies
- Receptor Functional Analysis
- Immunocytochemistry
- Apoptosis
- Pathogen Detection
- Compound Mediated Cytotoxicity
- Cell Viability and Proliferation
- Stem Cell Monitoring
- Gene expression
- Cell Culture Monitoring
- Angiogenesis
- Cell Cycle Analysis
- Other Application
- Drug Screening
By Technology:
- Impedance-Based Analysis
- Biosensors and Fluorescent Probes
- Fluorescence Microscopy
- Time-lapse microscopy
- Microfluidics-Based Systems
- Others
- Confocal Microscopy
- Total Internal Reflection Fluorescence (TIRF) Microscopy
By End User:
- Hospitals and Diagnostic Laboratories
- Pharma & Biopharmaceutical Companies
- Academic and Research Organization
- Contact Research Organization
Explore FMI's Extensive ongoing Coverage in Healthcare Domain:
Single Dose Radiotherapy Services Market Size: The global single-dose radiotherapy services market is expected to attain a valuation of US$ 7.88 billion in 2023 and is projected to reach US$ 16 billion by 2033, expanding at a CAGR of 7.3% during the forecast period.
Semen Analysis Systems Market Share: DNA fragmentation are also being analyzed. The rising number of cases of male infertility worldwide has impacted the child birth rate. Globally, infertility affects an estimated 15% of couples, amounting to 48.5 Mn couples.
Retinal Laser Photocoagulation Market Growth: The retinal laser photocoagulation market size is projected to be worth US$ 254.4 million in 2023. The market is likely to surpass US$ 399.9 million by 2033 at a CAGR of 4.6% during the forecast period.
Reusable Laparoscopic Instruments Market Trend: The reusable laparoscopic instruments market size is projected to be worth US$ 3.8 billion in 2023. The market is likely to surpass US$ 6.3 billion by 2033 at a CAGR of 5.1% during the forecast period.
Robot Assisted Surgical Microscope Market Forecast: The robot-assisted surgical microscope market size is projected to be worth US$ 410.6 million in 2023. The market is likely to surpass US$ 858.0 million by 2033 at a CAGR of 7.6% during the forecast period.
Cholesterol API Market Analysis: The global cholesterol active pharmaceutical ingredient (API) market size is expected to reach a valuation of US$ 280.6 million in 2023, and further expand at a CAGR of 4.7% during the forecast period from 2023 to 2033.
Throat Sprays Market Sales: The global throat sprays market is expected to reach a valuation of US$ 484.0 million in 2023. Sales of throat sprays are expected to gain traction at a 2.1% CAGR over the forecast period, with the market size reaching US$ 598.3 million by 2033.
Ovulation Microscope Market Outlook: The anticipated size of the ovulation microscope market in 2022 was US$ 48.9 million and is estimated to be US$ 54.9 million in 2023.
Veterinary Point of Care Market Volume: According to Future Market Insights research, during the projected period, the global veterinary point of care market is expected to grow at a CAGR of 8.2%. The market value is projected to increase from US$ 1.7 Billion in 2023 to US$ 3.8 Billion by 2033.
Melatonin Sleep Supplements Market Application: The anticipated size of the melatonin sleep supplements market in 2022 was US$ 474 million and is estimated to be US$ 508.3 million in 2023.
About Future Market Insights (FMI):
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.
Contact Us:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
LinkedIn | Twitter | Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com
